Effect of a gonadotropin-releasing hormone analogue on cyclophosphamide- induced ovarian toxicity in adult mice

Archives of Gynecology and Obstetrics

Volumn 287, Issue 5, 2013, Pages 1023-1029

  Kishk, Eman A Fouad ^a,b   Mohammed Ali, Mona H ^a  

^a Suez Canal University Faculty of Medicine   (Egypt)

^b NONE   (Egypt)

Author keywords

Cyclophosphamide; GnRH analogue; Ovarian toxicity; Premature ovarian failure

Indexed keywords

CYCLOPHOSPHAMIDE; DECAPEPTYL PR; TRIPTORELIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG MEGADOSE; FEMALE; FEMALE FERTILITY; HISTOPATHOLOGY; HORMONE ACTION; LOW DRUG DOSE; MOUSE; NONHUMAN; OVARIAN PRESERVATION; OVARIAN RESERVE; OVARIAN TOXICITY; OVARY FOLLICLE; TOXICITY;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FERTILITY PRESERVATION; GONADOTROPIN-RELEASING HORMONE; MICE; OVARY; PRIMARY OVARIAN INSUFFICIENCY; TRIPTORELIN PAMOATE;

EID: 84876668582     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2658-y     Document Type: Article

References (33)

1. Jarrell JF, Bodo L, YoungLai EV, Barr RD, O'Connell GJ (1991) The short-term reproductive toxicity of cyclophosphamide in the female rat. Reprod Toxicol 5:481-485
2. Bokser L, Szende B, Schally AV (1990) Protective effects of D-Trp6-luteinising hormone-releasing hormone microcapsules against cyclophosphamide-induced gonadotoxicity in female rats. Br J Cancer 61:861-865 (Pubitemid 20196992)
3. Lee SJ, Schover LR, Partridge AH et al (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:2917-2931 (Pubitemid 46655598)
4. Jeruss JS, Woodruff TK (2009) Preservation of fertility in patients with cancer. N Engl J Med 360:902-911
5. Ataya KM, McKanna JA, Weintraub AM, Clark MR, LeMaire WJ (1985) A luteinizing hormone-releasing hormone agonist for the prevention of chemotherapy-induced ovarian follicular loss in rats. Cancer Res 45:3651-3656 (Pubitemid 15226440)
6. Meistrich ML (1994) Failure to demonstrate hormonal protection of chemotherapy-induced fertility reduction in female rats. Reprod Toxicol 8:277-280
7. Marcello MF, Nuciforo G, Romeo R, Dino GD, Russo I, Russo A, Palumbo G, Schiliro G (1990) Structural and ultrastructural study of the ovary in childhood leukemia after successful treatment. Cancer 66:2099-2104
8. Tilly JL (2004) Pharmacological protection of female infertility. In: Tulandi T, Gosden R (eds) Preservation of fertility. Taylor and Francis, London, pp 65-75
9. Doll DC, Ringenberg QS, Yarbro JW (1986) Vascular toxicity associated with antineoplastic agents. J Clin Oncol 4:1405-1417 (Pubitemid 16028036)
10. Tan S, Yeh Y, Shang W, Wua G, Liu J (2010) Protective effect of a gonadotropin-releasing hormone analogue on chemotherapeutic agent-induced ovarian gonadotoxicity: a mouse model. Europ J Obstet Gynecol Reprod Biol 149:182-185
11. Meirow D, Lewis H, Nugent D, Epstein M (1999) Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum Reprod 14:1903-1911 (Pubitemid 29358724)
12. Myers M, Britt KL, Wreford NG, Ebling FJ, Kerr JB (2004) Methods for quantifying follicular numbers within the mouse ovary. Reproduction 127:569-580 (Pubitemid 38745074)
13. McGee EA, Hsueh AJ (2004) Initial and cyclic recruitment of ovarian follicles. Endocr Rev 21:200-214
14. Sonmezer M, Oktay K (2004) Fertility preservation in female patients. Hum Reprod Update 10:251-266 (Pubitemid 38744870)
15. Meirow D, Assad G, Dor and Rabinovici J (2004) The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice. Hum Reprod 19:1294-1299 (Pubitemid 38807699)
16. Ataya K, Rao L, Lawrence E, Kimmel R (1995) Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-lnduced ovarian follicular depletion in rhesus monkeys. Biol Reprod 52:365-372
17. Beck-Fruchter R, Weiss A, Shalev E (2008) GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data. Hum Reprod Update 14:553-561
18. Blumenfeld Z, von Wolff M (2008) GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod Update 14:543-552
19. Clowse ME, Behera MA, Anders CK et al (2009) Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J Womens Health (Larchmt) 18:311-319
20. Blumenfeld Z, Avivi I, Eckman A, Epelbaum R, Rowe JM, Dann EJ (2008) Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma. Fertil Steril 89:166-173
21. Del Mastro L, Boni L, Michelotti A, Gamucci T, Olmeo N et al (2011) Effect of the Gonadotropin-Releasing Hormone Analogue Triptorelin on the Occurrence of Chemotherapy-Induced Early Menopause in Premenopausal Women With Breast Cancer. JAMA 306(3):269-276
22. Emons G, Grundker C, Gunthert AR, Westphalen S, Kavanagh J, Verschraegen C (2003) GnRH antagonists in the treatment of gynecological and breast cancers. Endocr Relat Cancer 10:291-299 (Pubitemid 36758655)
23. LHRH-agonists in Early Breast Cancer Overview group, Cuzick J, Ambroisine L, Davidson N, Jakesz R, Kaufmann M, Regan M, Sainsbury R (2007) Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials. Lancet 369:1711-1723 (Pubitemid 46755389)
24. Ataya KM, Tadros M, Ramahi A (1989) Gonadotropin-releasing hormone agonist inhibits physiologic ovarian follicular loss in rats. Acta Endocrinol 121:55-60 (Pubitemid 19167531)
25. Dada T, Salha O, Allgar V, Sharma V (2001) Utero-ovarian blood flow characteristics of pituitary desensitization. Hum Reprod 16:1663-1670 (Pubitemid 32761747)
26. Oktay K, Briggs D, Gosden RG (1997) Ontogeny of follicle-stimulating hormone receptor gene expression in isolated human ovarian follicles. J Clin Endocrinol Metab 82:3748-3751 (Pubitemid 27509366)
27. Lunenfeld E, Schwartz I, Meizner I, Potashnik G, Glezerman M (1996) Intraovarian blood flow during spontaneous and stimulated cycles. Hum Reprod 11:2481-2483 (Pubitemid 27007461)
28. Tan SL, Zaidi J, Campbell S, Doyle P, Collins W (1996) Blood flow changes in the ovarian and uterine arteries during the normal menstrual cycle. Am J Obstet Gynecol 175:625-631 (Pubitemid 26353260)
29. Faddy MJ, Gosden RG (1995) A mathematical model of follicle dynamics in the human ovary. Hum Reprod 10:770-775
30. Singh P, Krishna A (2010) Effects of GnRH agonist treatment on steroidgenesis and folliculogenesis in the ovary of cyclic mice. J Ovarian Res 3:26-38
31. Plowchalk DR, Mattison DR (1991) Reproductive toxicity of cyclophosphamide in the C57BL/6 N mouse: 1. Effects on ovarian structure and function. Reprod Toxicol 6:411-421
32. Matsuo G, Ushijima K, Shinagawa A et al (2007) GnRH agonist acts as ovarian protection in chemotherapy induced gonadotoxicity: an experiment using a rat model. Kurume Med J 54:25-29 (Pubitemid 351486930)
33. Blumenfeld Z, Avivi I, Linn S et al (1996) Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a Gonadotropin-releasing hormone agonist in parallel to chemotherapy. Human Reprod 11:1620-1626 (Pubitemid 26318897)